Insufficient scRNA-seq data for expression of GBA3 at single-cell level.
Insufficient scRNA-seq data for expression of GBA3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 3468.56 | 89 / 89 | 83% | 89.84 | 749 / 901 |
liver | 100% | 3111.96 | 226 / 226 | 73% | 24.06 | 297 / 406 |
spleen | 100% | 408.22 | 240 / 241 | 0% | 0 | 0 / 0 |
intestine | 58% | 991.61 | 560 / 966 | 13% | 1.05 | 68 / 527 |
thymus | 54% | 15.79 | 353 / 653 | 2% | 0.11 | 11 / 605 |
lung | 45% | 16.01 | 262 / 578 | 7% | 0.69 | 76 / 1155 |
pancreas | 37% | 12.27 | 120 / 328 | 15% | 1.73 | 27 / 178 |
prostate | 24% | 8.33 | 60 / 245 | 1% | 0.06 | 6 / 502 |
stomach | 10% | 2.47 | 36 / 359 | 12% | 1.44 | 33 / 286 |
lymph node | 0% | 0 | 0 / 0 | 21% | 1.52 | 6 / 29 |
breast | 19% | 5.37 | 87 / 459 | 1% | 0.09 | 15 / 1118 |
bladder | 5% | 1.10 | 1 / 21 | 6% | 0.67 | 30 / 504 |
brain | 9% | 2.20 | 234 / 2642 | 2% | 0.13 | 11 / 705 |
ovary | 4% | 1.41 | 8 / 180 | 5% | 0.29 | 23 / 430 |
uterus | 6% | 5.82 | 10 / 170 | 3% | 0.17 | 13 / 459 |
skin | 4% | 0.86 | 65 / 1809 | 4% | 0.29 | 19 / 472 |
esophagus | 2% | 1.08 | 29 / 1445 | 5% | 0.66 | 10 / 183 |
adrenal gland | 7% | 1.29 | 18 / 258 | 0% | 0.06 | 1 / 230 |
peripheral blood | 4% | 1.39 | 35 / 929 | 0% | 0 | 0 / 0 |
adipose | 4% | 1.21 | 43 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 2% | 0.37 | 27 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 0.10 | 2 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016139 | Biological process | glycoside catabolic process |
GO_0006683 | Biological process | galactosylceramide catabolic process |
GO_1901805 | Biological process | beta-glucoside catabolic process |
GO_0009313 | Biological process | oligosaccharide catabolic process |
GO_0050821 | Biological process | protein stabilization |
GO_0046477 | Biological process | glycosylceramide catabolic process |
GO_1903017 | Biological process | positive regulation of exo-alpha-sialidase activity |
GO_0006680 | Biological process | glucosylceramide catabolic process |
GO_0046479 | Biological process | glycosphingolipid catabolic process |
GO_1902494 | Cellular component | catalytic complex |
GO_0005829 | Cellular component | cytosol |
GO_0004336 | Molecular function | galactosylceramidase activity |
GO_0102483 | Molecular function | scopolin beta-glucosidase activity |
GO_0004565 | Molecular function | beta-galactosidase activity |
GO_0008422 | Molecular function | beta-glucosidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0017042 | Molecular function | glycosylceramidase activity |
GO_0004348 | Molecular function | glucosylceramidase activity |
Gene name | GBA3 |
Protein name | Glucosidase, beta, acid 3 (Cytosolic) (cDNA FLJ78196, highly similar to Homo sapiens glucosidase, beta, acid 3 (cytosolic) (GBA3), mRNA) (cDNA, FLJ93688, Homo sapiens glucosidase, beta, acid 3 (cytosolic) (GBA3), mRNA) Cytosolic beta-glucosidase (EC 3.2.1.21) (Cytosolic beta-glucosidase-like protein 1) (Cytosolic galactosylceramidase) (EC 3.2.1.46) (Cytosolic glucosylceramidase) (EC 3.2.1.45) (Cytosolic glycosylceramidase) (Cytosolic GCase) (Glucosidase beta acid 3) (Glucosylceramidase beta 3) (Klotho-related protein) (KLrP) |
Synonyms | CBG CBGL1 hCG_40508 |
Description | FUNCTION: Neutral cytosolic beta-glycosidase with a broad substrate specificity that could play a role in the catabolism of glycosylceramides . Has a significant glucosylceramidase activity in vitro . However, that activity is relatively low and its significance in vivo is not clear . Hydrolyzes galactosylceramides/GalCers, glucosylsphingosines/GlcSphs and galactosylsphingosines/GalSphs . However, the in vivo relevance of these activities is unclear . It can also hydrolyze a broad variety of dietary glycosides including phytoestrogens, flavonols, flavones, flavanones and cyanogens in vitro and could therefore play a role in the metabolism of xenobiotics . Possesses transxylosylase activity in vitro using xylosylated ceramides/XylCers (such as beta-D-xylosyl-(1<->1')-N-acylsphing-4-enine) as xylosyl donors and cholesterol as acceptor . Could also play a role in the catabolism of cytosolic sialyl free N-glycans . . |
Accessions | A8K9N1 ENST00000709220.1 [Q9H227-1] Q9H227 ENST00000709221.1 [Q9H227-2] |